Biopsy-based calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan

Journal of Cardiovascular Magnetic Resonance

Volumn 16, Issue 1, 2014, Pages

  Garbowski, Maciej W ^a,b   Carpenter, John Paul ^c,d   Smith, Gillian ^c,d   Roughton, Michael ^e   Alam, Mohammed H ^c,d   He, Taigang ^c,f   Pennell, Dudley J ^c,d   Porter, John B ^a,b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

^f ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Calibration; Clinical iron overload; Liver biopsy; Liver iron; Magnetic resonance; Thalassemia

Indexed keywords

DEFERASIROX; IRON;

ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTROLLED STUDY; DRY WEIGHT; HEMOSIDEROSIS; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; IRON CHELATION; IRON OVERLOAD; LIVER; LIVER BIOPSY; LIVER IRON CONCENTRATION; LIVER WEIGHT; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; REPRODUCIBILITY; RETROSPECTIVE STUDY;

ALGORITHMS; BENZOATES; BIOLOGICAL MARKERS; BIOPSY; BLOOD TRANSFUSION; CALIBRATION; HEMOSIDEROSIS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IRON; IRON CHELATING AGENTS; LEAST-SQUARES ANALYSIS; LINEAR MODELS; LIVER; MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TRIAZOLES;

EID: 84903161744     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-16-40     Document Type: Article

References (39)

1. Hepatic iron concentration and total body iron stores in thalassemia major. Angelucci E, Brittenham GM, McLaren CE, Ripalti M, Baronciani D, Giardini C, Galimberti M, Polchi P, Lucarelli G, N Engl J Med 2000 343 327 331 10.1056/NEJM200008033430503 10922422 (Pubitemid 30616698)
2. Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study. Porter J, Galanello R, Saglio G, Neufeld EJ, Vichinsky E, Cappellini MD, Olivieri N, Piga A, Cunningham MJ, Soulieres D, Gattermann N, Tchernia G, Maertens J, Giardina P, Kwiatkowski J, Quarta G, Jeng M, Forni GL, Stadler M, Cario H, Debusscher L, Della Porta M, Cazzola M, Greenberg P, Alimena G, Rabault B, Gathmann I, Ford JM, Alberti D, Rose C, Eur J Haematol 2008 80 168 176 18028431
3. A randomized controlled 1-year study of daily deferiprone plus twice weekly desferrioxamine compared with daily deferiprone monotherapy in patients with thalassemia major. Aydinok Y, Ulger Z, Nart D, Terzi A, Cetiner N, Ellis G, Zimmermann A, Manz C, Haematologica 2007 92 1599 1606 10.3324/haematol.11414 18055982 (Pubitemid 350248238)
4. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, Aydinok Y, Kattamis A, Kilinc Y, Porter J, Capra M, Galanello R, Fattoum S, Drelichman G, Magnano C, Verissimo M, Athanassiou-Metaxa M, Giardina P, Kourakli-Symeonidis A, Janka-Schaub G, Coates T, Vermylen C, Olivieri N, Thuret I, Opitz H, Ressayre-Djaffer C, Marks P, Alberti D, Blood 2006 107 3455 3462 10.1182/blood-2005-08-3430 16352812
5. Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major. Brittenham GM, Cohen AR, McLaren CE, Martin MB, Griffith PM, Nienhuis AW, Young NS, Allen CJ, Farrell DE, Harris JW, Am J Hematol 1993 42 81 85 10.1002/ajh.2830420116 8416302 (Pubitemid 23008317)
6. Transfusion and exchange transfusion in sickle cell anaemias, with particular reference to iron metabolism. Porter JB, Huehns ER, Acta Haematol 1987 78 198 205 3120472 (Pubitemid 18021123)
7. Effect of ascorbic acid deficiency on serum ferritin concentration in patients with beta-thalassaemia major and iron overload. Chapman RW, Hussain MA, Gorman A, Laulicht M, Politis D, Flynn DM, Sherlock S, Hoffbrand AV, J Clin Pathol 1982 35 487 491 10.1136/jcp.35.5.487 7085892 (Pubitemid 12116757)
8. Liver iron concentrations and urinary hepcidin in beta-thalassemia. Origa R, Galanello R, Ganz T, Giagu N, Maccioni L, Faa G, Nemeth E, Haematologica 2007 92 583 588 10.3324/haematol.10842 17488680 (Pubitemid 350144260)
9. Ferritin trends do not predict changes in total body iron in patients with transfusional iron overload. Puliyel M, Sposto R, Berdoukas VA, Hofstra TC, Nord A, Carson S, Wood J, Coates TD, Am J Hematol 2014 89 4 391 394 10.1002/ajh.23650 24347294
10. Correlations of serum ferritin (sf) and liver iron concentration before and after 1 year of deferasirox treatment. Porter J, Elalfy M, Aydinok Y, Chan A, Lee S, Sutcharitchan P, Taher A, Habr D, Roubert B, El-Beshlawy A, Haematologia 2010 95 suppl.2 708
11. Noninvasive methods for quantitative assessment of transfusional iron overload in sickle cell disease. Brittenham GM, Sheth S, Allen CJ, Farrell DE, Semin Hematol 2001 38 37 56 (Pubitemid 32110271)
12. Monitoring long-term efficacy of iron chelation treatment with biomagnetic liver susceptometry. Fischer R, Piga A, Harmatz P, Nielsen P, Ann N Y Acad Sci 2005 1054 350 357 10.1196/annals.1345.043 16339683 (Pubitemid 43031042)
13. Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Jensen PD, Jensen FT, Christensen T, Eiskjaer H, Baandrup U, Nielsen JL, Blood 2003 101 4632 4639 10.1182/blood-2002-09-2754 12576333 (Pubitemid 36857840)
14. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. St Pierre TG, Clark PR, Chua-anusorn W, Fleming AJ, Jeffrey GP, Olynyk JK, Pootrakul P, Robins E, Lindeman R, Blood 2005 105 855 861 10.1182/blood-2004-01-0177 15256427 (Pubitemid 40070775)
15. Non-invasive assessment of hepatic iron stores by MRI. Gandon Y, Olivie D, Guyader D, Aube C, Oberti F, Sebille V, Deugnier Y, Lancet 2004 363 357 362 10.1016/S0140-6736(04)15436-6 15070565 (Pubitemid 38169542)
16. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, Pennell DJ, Eur Heart J 2001 22 2171 2179 10.1053/euhj.2001.2822 11913479 (Pubitemid 33139463)
17. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, Coates TD, Blood 2005 106 1460 1465 10.1182/blood-2004-10-3982 15860670 (Pubitemid 41129616)
18. R2* magnetic resonance imaging of the liver in patients with iron overload. Hankins JS, McCarville MB, Loeffler RB, Smeltzer MP, Onciu M, Hoffer FA, Li CS, Wang WC, Ware RE, Hillenbrand CM, Blood 2009 113 4853 4855 10.1182/blood-2008-12-191643 19264677
19. Semi-quantitative assessment of hemosiderin distribution accurately reflects reductions in liver iron concentration following therapy with Deferasirox (exjade®, ICL670) or Deferoxamine in patients with transfusion-dependent anemia. Deugnier Y, Turlin B, Ropert M, Bejaoui M, Athanassiou-Metaxa M, Cario H, Vichinsky E, Opitz H, Ressayre-Djaffer C, Rabault B, Ford J, Blood 2005 106 11 Suppl bstract 2708
20. Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion- dependent anemias. Cappellini MD, Porter J, El-Beshlawy A, Li CK, Seymour JF, Elalfy M, Gattermann N, Giraudier S, Lee JW, Chan LL, Lin KH, Rose C, Taher A, Thein SL, Viprakasit V, Habr D, Domokos G, Roubert B, Kattamis A, Investigators, Epic Study, Haematologica 2010 95 557 566 10.3324/haematol.2009.014696 19951979
21. A comparative study of flame atomic-absorption methods for determination of zinc in serum and blood plasma. Soriano MJ, de la Guardia M, Talanta 1984 31 347 352 10.1016/0039-9140(84)80094-6 18963608
22. Drying methods affect the wet dry ratio of liver tissue samples and impact on iron content measurements. Ropert-Bouchet M, Turlin B, Graham G, Rabault B, Le Treut A, Brissot P, Loreal O, Alberti D, Deugnier Y, BioIron 2005 107 bstract P274
23. Multi-center transferability of a breath-hold T2 technique for myocardial iron assessment. He T, Kirk P, Firmin DN, Lam WM, Chu WC, Au WY, Chan GC, Tan RS, Ng I, Biceroglu S, Aydinok Y, Fogel MA, Cohen AR, Pennell DJ, J Cardiovasc Magn Reson 2008 10 11 10.1186/1532-429X-10-11 18291040
24. Efficacy and safety of deferasirox at low and high iron burdens: results from the EPIC magnetic resonance imaging substudy. Porter JB, Elalfy MS, Taher AT, Aydinok Y, Chan LL, Lee SH, Sutcharitchan P, Habr D, Martin N, El-Beshlawy A, Ann Hematol 2013 92 211 219 10.1007/s00277-012-1588-x 23086508
25. Measuring agreement in method comparison studies. Bland JM, Altman DG, Stat Methods Med Res 1999 8 135 160 10.1191/096228099673819272 10501650 (Pubitemid 29425900)
26. Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron. Tanner MA, He T, Westwood MA, Firmin DN, Pennell DJ, Haematologica 2006 91 1388 1391 17018390 (Pubitemid 44569814)
27. Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies. Angelucci E, Baronciani D, Lucarelli G, Baldassarri M, Galimberti M, Giardini C, Martinelli F, Polchi P, Polizzi V, Ripalti M, Muretto P, Br J Haematol 1995 89 757 761 7772512
28. Quantitative study of the variability of hepatic iron concentrations. Emond MJ, Bronner MP, Carlson TH, Lin M, Labbe RF, Kowdley KV, Clin Chem 1999 45 340 346 10053034 (Pubitemid 29114168)
29. Measurement of liver-iron concentration in needle biopsy specimens. Barry M, Sherlock S, Lancet 1971 1 100 103 4099600
30. Measurement of iron in liver biopsies-a comparison of three analytical methods. Kreeftenberg HG, Koopman BJ, Huizenga JR, van Vilsteren T, Wolthers BG, Gips CH, Clin Chim Acta 1984 144 255 262 10.1016/0009-8981(84)90061-5 6529859 (Pubitemid 15196362)
31. Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia. Westwood MA, Anderson LJ, Firmin DN, Gatehouse PD, Lorenz CH, Wonke B, Pennell DJ, J Magn Reson Imaging 2003 18 616 620 10.1002/jmri.10396 14579406 (Pubitemid 37345172)
32. International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers. Kirk P, He T, Anderson LJ, Roughton M, Tanner MA, Lam WW, Au WY, Chu WC, Chan G, Galanello R, Matta G, Fogel M, Cohen AR, Tan RS, Chen K, Ng I, Lai A, Fucharoen S, Laothamata J, Chuncharunee S, Jongjirasiri S, Firmin DN, Smith GC, Pennell DJ, J Magn Reson Imaging 2010 32 315 319 10.1002/jmri.22245 20677256
33. Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration. St Pierre TG, El-Beshlawy A, Elalfy M, Al Jefri A, Al Zir K, Daar S, Habr D, Kriemler-Krahn U, Taher A, Magn Reson Med 2014 71 6 2215 2223 10.1002/mrm.24854 23821350
34. Comparison of whole liver and small region-of-interest measurements of MRI liver R2* in children with iron overload. McCarville MB, Hillenbrand CM, Loeffler RB, Smeltzer MP, Song R, Li CS, Hankins JS, Pediatr Radiol 2010 40 1360 1367 10.1007/s00247-010-1596-8 20333511
35. Relaxivity-iron calibration in hepatic iron overload: probing underlying biophysical mechanisms using a Monte Carlo model. Ghugre NR, Wood JC, Magn Reson Med 2011 65 837 847 10.1002/mrm.22657 21337413
36. R2 and R2* are equally effective in evaluating chronic response to iron chelation. Wood JC, Zhang P, Rienhoff H, Abi-Saab W, Neufeld E, Am J Hematol 2014 89 5 505 508 10.1002/ajh.23673 24452753
37. Disparities between Two common MRI metrics of liver iron concentration in transfusional siderosis. Wood JC, Jones A, Rienhoff HY Jr, Neufeld EJ, ASH Ann Meeting Abstracts 2011 118 1088
38. Variability in hepatic iron concentration in percutaneous needle biopsy specimens from patients with transfusional hemosiderosis. Butensky E, Fischer R, Hudes M, Schumacher L, Williams R, Moyer TP, Vichinsky E, Harmatz P, Am J Clin Pathol 2005 123 146 152 10.1309/PUUXEGXDLH26NXA2 15762291 (Pubitemid 40066182)
39. Improved MRI R2* relaxometry of iron-loaded liver with noise correction. Feng Y, He T, Gatehouse PD, Li X, Harith Alam M, Pennell DJ, Chen W, Firmin DN, Magn Reson Med 2013 70 6 1765 1774 10.1002/mrm.24607 23359410